| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/02/2013 | US8410252 ULBP2 polypeptides |
| 04/02/2013 | US8410251 Antibody against calcified globule and use of the same |
| 04/02/2013 | US8410250 Anti-FGFR3 antibodies and methods using same |
| 04/02/2013 | US8410249 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8410058 Methods of using insulin-like growth factor antibodies to treat tumors |
| 04/02/2013 | US8409838 Fucosylation-deficient cells |
| 04/02/2013 | US8409836 Treatment of cellulosic material and enzymes useful therein |
| 04/02/2013 | US8409828 Animal product free system and process for purifying a botulinum toxin |
| 04/02/2013 | US8409827 Nitrate reductase fusion proteins and uses thereof |
| 04/02/2013 | US8409825 Method for high-level secretory production of protein |
| 04/02/2013 | US8409642 Ferulate esterase-producing bacterial strain for enhancing plant fiber digestion in an animal |
| 04/02/2013 | US8409589 Mutant forms of streptolysin O |
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409576 Use of IL-1beta compounds |
| 04/02/2013 | US8409572 Monoclonal antibodies with enhanced ADCC function |
| 04/02/2013 | CA2586128C Enzymatic reactions in the presence of keto acids |
| 04/02/2013 | CA2553883C Anti-cancer antibodies with reduced complement fixation |
| 04/02/2013 | CA2494105C Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 04/02/2013 | CA2453062C Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 04/02/2013 | CA2402131C Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
| 03/28/2013 | WO2013044225A1 A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens |
| 03/28/2013 | WO2013044215A1 Vegf/dll4 binding agents and uses thereof |
| 03/28/2013 | WO2013043860A1 Endogenous dnase activity to reduce dna content |
| 03/28/2013 | WO2013043452A1 Anti-c-met antibodies |
| 03/28/2013 | WO2013042960A2 Method for preparing microvesicular adam15 |
| 03/28/2013 | WO2013041487A1 Co2 profile cultivation |
| 03/28/2013 | WO2013040688A1 Enhancement of eukaryotic cell properties using ultrasound |
| 03/28/2013 | WO2013016428A9 Recombinant apoa-1m from engineered bacteria |
| 03/28/2013 | WO2013006479A3 Mammalian cell culture |
| 03/28/2013 | WO2012178102A3 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
| 03/28/2013 | WO2012170807A3 Anti-pseudomonas psl binding molecules and uses thereof |
| 03/28/2013 | US20130078672 Polypeptides having xylanase activity and polynucleotides encoding same |
| 03/28/2013 | US20130078671 Incorporation of two different noncanonical amino acids into a single protein |
| 03/28/2013 | US20130078658 Method of quantifying recovery rate of exosome |
| 03/28/2013 | CA2848421A1 Endogenous dnase activity to reduce dna content |
| 03/28/2013 | CA2843771A1 Anti-c-met antibodies |
| 03/27/2013 | EP2573175A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 03/27/2013 | EP2573174A1 Ketoreductase mutant |
| 03/27/2013 | EP2573122A2 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins |
| 03/27/2013 | EP2573120A1 Anti-human trop-2 antibody having anti-tumor activity in vivo |
| 03/27/2013 | CN103003438A Method of reducing glycosylation of proteins, processes and proteins thereof |
| 03/27/2013 | CN103003424A Antibody capable of binding to transforming growth factor alpha and having antiproliferative activity on cancer having Ras gene mutation |
| 03/27/2013 | CN103002906A Parathyroid hormone analogs and uses thereof |
| 03/27/2013 | CN102994605A Method for producing high-efficiency biological peptide through enzymolysis and microbe fermentation |
| 03/27/2013 | CN102994602A Preparation method of compound oligopeptide with high F value |
| 03/27/2013 | CN102994601A Method for preparing collagen small peptide by utilizing marine collagenase MCP-01 |
| 03/27/2013 | CN102994600A Enzyme digestion transformation method of insulin glargine precursor |
| 03/27/2013 | CN102994599A Antioxidant active peptide and preparation method by ultrasonic electrophoresis separation |
| 03/27/2013 | CN102994598A Weak bitter corn oligopeptide with high content of alanine and leucine, and preparation method thereof |
| 03/27/2013 | CN102994597A Method for extracting collagen peptide from squid skin through chymotryptic hydrolysis |
| 03/27/2013 | CN102994596A Induction of expression of recombinant chicken alpha interferon in escherichia coli by lactose instead of IPTG |
| 03/27/2013 | CN102994595A Preparation method of fusion protein inclusion body |
| 03/27/2013 | CN102994442A Animal cell suspension culture process utilizing riptide bioreactor, and controlling method thereof |
| 03/27/2013 | CN102994418A Methylotrophic bacillus for producing surfactins and iturin A compounds and application of methylotrophic bacillus |
| 03/27/2013 | CN102994213A Method for preparing crude fish oil, collagen peptide and hydroxyapatite by using scaled fish skin |
| 03/27/2013 | CN102994209A Method for synchronously extracting soybean oil and soybean protein through aqueous enzymatic method |
| 03/27/2013 | CN102993314A Anti-tumor fusion protein, as well as preparation method and application thereof |
| 03/27/2013 | CN102993309A Human auxin fusion protein TAT-hGH as well as preparation method and application thereof |
| 03/27/2013 | CN102993306A High affinity, anti-human IgE antibodies |
| 03/27/2013 | CN102993303A Anti-interferon- alpha antibodies |
| 03/27/2013 | CN102993282A Insecticidal protein and coding gene and application thereof |
| 03/27/2013 | CN102993281A Insecticidal protein and coding gene and application thereof |
| 03/27/2013 | CN102993280A Insecticidal protein and coding gene and application thereof |
| 03/27/2013 | CN102993279A Insecticidal protein and coding gene and application thereof |
| 03/27/2013 | CN102993269A Cyclo-tetrapeptide compounds, preparation method thereof and application of cyclo-tetrapeptide compounds in preparation of anti-fouling agent |
| 03/27/2013 | CN102392008B Bioprotein capable of replacing protein raw material and preparation method of bioprotein |
| 03/27/2013 | CN102250233B Royal jelly polypeptide and application thereof |
| 03/27/2013 | CN101928728B Method for preparing enterovirus virus-like particle and application thereof |
| 03/27/2013 | CN101921820B Preparation method of recombinant tumor specificity antiapoptotic factors with activity and application of products thereof |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101555485B Non-fusion expression of recombinant human parathyroid hormone (1-84) and large-scale preparation method |
| 03/27/2013 | CN101528777B Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 03/27/2013 | CN101405401B Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 03/27/2013 | CN101294159B Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection |
| 03/27/2013 | CN101287765B 基因修饰的抗体组成物 Gene modified antibody composition |
| 03/27/2013 | CN101273141B Targeted integration and expression of exogenous nucleic acid sequences |
| 03/27/2013 | CN101247830B TWEAK binding antibodies |
| 03/27/2013 | CN101213294B Scalable fermentation process |
| 03/27/2013 | CN101171334B Methods of producing proteins having triple-helix structure |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101061225B Methods and compositions for concentrating secreted recombinant protein |
| 03/26/2013 | US8404825 Method for producing monoterpene and monoterpinoid compounds and use thereof |
| 03/26/2013 | US8404817 Humanized anti-prostate stem cell antigen monoclonal antibody |
| 03/26/2013 | US8404816 Methods for antibody engineering |
| 03/26/2013 | US8404815 Chimeric, humanized, or human antibody 2A4 |
| 03/26/2013 | US8404807 Mammalian tumor susceptibility genes and their uses |
| 03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 03/26/2013 | US8404471 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities |
| 03/26/2013 | US8404466 Metabolically enhanced photoautotrophic ethanol producing host cells, method for producing the host cells, constructs for the transformation of the host cells, and method of producing ethanol using the host cells |
| 03/26/2013 | US8404462 Synthetic pathway enzymes for the production of argyrins |
| 03/26/2013 | US8404235 Antagonists of IL-6 to raise albumin and/or lower CRP |
| 03/26/2013 | US8404233 Neutralizing monoclonal antibody against human DLL4 |
| 03/26/2013 | US8404231 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 03/26/2013 | CA2791109A1 Generation of binding molecules |
| 03/26/2013 | CA2643994C Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins |
| 03/26/2013 | CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application |
| 03/21/2013 | WO2013040307A1 Methods of making cells, tissues, and antibodies |
| 03/21/2013 | WO2013011368A9 Novel il-17r-ecd mutants |